Acute toxicity in cervical cancer HIV-positive vs. HIV-negative patients treated by radical chemo-radiation in Zambia
Open Access
- 25 October 2016
- journal article
- research article
- Published by Taylor & Francis Ltd in Southern African Journal of Gynaecological Oncology
- Vol. 8 (2), 37-41
- https://doi.org/10.1080/20742835.2016.1239356
Abstract
Background: The current standard of radical treatment for patients with cancer of the cervix is combination therapy in the form of radiotherapy with chemotherapy. Generally the same treatment protocol is applied to HIV-positive and HIV-negative patients. However, HIV-positive patients with invasive cervical cancer have not been evaluated in detail regarding treatment response, its toxicities and compliance. Methods: This prospective, quantitative comparative study was conducted to evaluate acute toxicity in radical combination therapy, in HIV-positive (on HAART) and HIV-negative patients for cervical cancer at the Cancer Diseases Hospital, Lusaka, Zambia. In total, 120 stage IB2–IIIB cervical cancer patients were serially recruited to have an equal number of participants in each arm. Participants received cisplatin-based radical chemo-radiation for five to six weeks and were assessed for acute reactions in four systems: genitourinary, haematopoietic, skin, and gastrointestinal. Toxicity was scored using the NCI CTC v2.0. Results: The results revealed that there was no significant difference with regard to major acute reactions between the two groups. Radical chemo-radiation is therefore well tolerated by HIV-positive patients. Conclusion: Radical chemo-radiation in conventional doses was safely tolerated by a well-selected cervical cancer HIV-positive group on HAART and could be considered suitable for similar patients.Keywords
This publication has 12 references indexed in Scilit:
- Srinagarind Hospital experience in concurrent chemoradiation for 100 patients with stage IB2 to IVA uterine cervical cancerRadiation Medicine, 2007
- Contraindications to cisplatin based chemoradiotherapy in the treatment of cervical cancer in Sub-Saharan AfricaRadiotherapy and Oncology, 2007
- HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancerGynecologic Oncology, 2006
- HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcomeRadiotherapy and Oncology, 2005
- Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: A report on patient compliance and acute toxicityInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Acute Toxicity of Chemo-radiotherapy for Cervical Cancer: The Addenbrooke’s ExperienceClinical Oncology, 2004
- Usefulness of Preoperative Chemoradiation in Locally Advanced Cervical CarcinomaGynecologic and Obstetric Investigation, 2004
- Phase III Trial Comparing Radical Radiotherapy With and Without Cisplatin Chemotherapy in Patients With Advanced Squamous Cell Cancer of the CervixJournal of Clinical Oncology, 2002
- Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical CarcinomaThe New England Journal of Medicine, 1999
- Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical CancerThe New England Journal of Medicine, 1999